Národny ustav srdcovych a cievnych chorob a.s.

Cardiology

The clinical research activity of Národny ustav srdcovych a cievnych chorob a.s. is centered on cardiovascular medicine, with a clear focus on atrial fibrillation and rhythm-related care.

  • Persistent symptomatic atrial fibrillation
  • Atrial tachyarrhythmia recurrence
  • Heart rhythm disorders

The sponsor’s research interest is directed toward clinical strategies for managing ongoing symptomatic AF in a hospital-based setting.

Electrophysiology

Its trial portfolio includes interventional approaches in cardiac electrophysiology, particularly treatments designed to restore and maintain normal rhythm in patients with early disease.

  • Pulmonary vein isolation
  • Catheter ablation
  • Rhythm control

Research activity in this area reflects a focus on procedural management of arrhythmia rather than long-term symptomatic treatment alone.

Interventional arrhythmia treatment

The sponsor is involved in evaluating early interventional care for persistent atrial fibrillation, with attention to procedural options used as first-line therapy.

  • Cryoballoon ablation
  • First-line therapy
  • Antiarrhythmic drugs

This area of interest links device-based intervention with comparisons against established drug-based rhythm management.

Multicentre cardiovascular research

Clinical activity extends across a network of collaborating sites in multiple countries, supporting research in cross-border cardiology and specialist heart-rhythm care.

  • Collaborative research sites
  • International trial participation
  • Hospital-based clinical research

The sponsor’s research landscape is concentrated on specialist cardiac care within a coordinated clinical network.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Early Treatment of Persistent Atrial Fibrillation: Comparing Cryoballoon Therapy with Dronedarone, Flecainide, Sotalol, and Propafenone in Symptomatic Patients

    Recruiting

    1 1 1 1
    Investigated drugs:
    Bulgaria Denmark Germany Hungary Norway Slovakia +1